Hims & Hers Health, Inc. (NYSE: HIMS), the leading global health and wellness platform, recently announced it is now serving customers in Australia, marking the company’s first-ever presence in the Asia-Pacific market. The entry follows Hims & Hers’ acquisition of Eucalyptus earlier this year and begins with the rebrand of Pilot, Eucalyptus’ men’s health platform, marking the first Eucalyptus brand to transition to the Hims brand.
Australia represents a meaningful growth opportunity for Hims & Hers’ international business. The country’s telehealth sector is projected to grow to USD 2.56 billion by 2034. We expect the Australian market to play an important role in helping us reach USD 1B in international annual revenue within the next three years. That opportunity is underscored by unmet demand: nearly 30% of Pilot’s patients live in regional and rural Australia, where getting care for some of the most important health issues men face has too often meant a long drive, a long wait, or going without. Pairing Pilot’s local trust and clinical expertise with Hims & Hers’ proven digital platform is designed to convert that need into durable growth.
Effective today, Pilot becomes Hims. Customers will keep the treatment plans and provider relationships they rely on, now backed by the world’s largest consumer health platform.
“Eucalyptus started in Australia, and it feels right that our journey with Hims starts here too,” said Tim Doyle, founder and former CEO of Eucalyptus, now Senior Vice President of International at Hims & Hers. “Pilot proved that Australian men want a different model of healthcare: one that’s proactive, personal, and built around their lives. Responding to that demand is the next step of our journey. We’re taking everything we learned in Pilot’s first years and using it to help even more men get the care they need, in Australia and beyond.”
“As a practising GP, I’ve seen how often men wait too long to act on something that was manageable if caught early,” said Matt Vickers, FRACGP, MBBS, BMedSci, AICGG, Chief Medical Officer of Hims Australia. “This launch doesn’t trade clinical rigor for convenience — every treatment plan is grounded in the same evidence-based standards I’d want for my own patients, just delivered in a way that fits into a man’s life instead of asking him to work around it. That’s how we actually move the needle on men’s health outcomes here, not just access to it.”
To best serve Australian customers, Hims is investing in localized leadership and specialized medical expertise. Tim Doyle will oversee the Australian market alongside Gus Wood, General Manager of Australia. Dr. Matt Vickers, FRACGP, MBBS, BMedSci, AICGG, will serve as Chief Medical Officer of Hims Australia, ensuring care is grounded in local clinical standards.
